[1]
Chin JH, Tuberculous meningitis: Diagnostic and therapeutic challenges. Neurology. Clinical practice. 2014 Jun;
[PubMed PMID: 25110618]
[2]
Soria J,Metcalf T,Mori N,Newby RE,Montano SM,Huaroto L,Ticona E,Zunt JR, Mortality in hospitalized patients with tuberculous meningitis. BMC infectious diseases. 2019 Jan 5;
[PubMed PMID: 30611205]
[3]
Lee SA,Kim SW,Chang HH,Jung H,Kim Y,Hwang S,Kim S,Park HK,Lee JM, A New Scoring System for the Differential Diagnosis between Tuberculous Meningitis and Viral Meningitis. Journal of Korean medical science. 2018 Jul 30;
[PubMed PMID: 30069169]
[4]
Bourgi K,Fiske C,Sterling TR, Tuberculosis Meningitis. Current infectious disease reports. 2017 Sep 11;
[PubMed PMID: 28895024]
[5]
Thwaites G,Chau TT,Mai NT,Drobniewski F,McAdam K,Farrar J, Tuberculous meningitis. Journal of neurology, neurosurgery, and psychiatry. 2000 Mar;
[PubMed PMID: 10675209]
[6]
Chan KH,Cheung RT,Lee R,Mak W,Ho SL, Cerebral infarcts complicating tuberculous meningitis. Cerebrovascular diseases (Basel, Switzerland). 2005
[PubMed PMID: 15863982]
[7]
Farinha NJ,Razali KA,Holzel H,Morgan G,Novelli VM, Tuberculosis of the central nervous system in children: a 20-year survey. The Journal of infection. 2000 Jul
[PubMed PMID: 10942642]
Level 3 (low-level) evidence
[8]
Udani PM,Dastur DK, Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations. Journal of the neurological sciences. 1970 Jun
[PubMed PMID: 5422557]
[9]
Marx GE,Chan ED, Tuberculous meningitis: diagnosis and treatment overview. Tuberculosis research and treatment. 2011;
[PubMed PMID: 22567269]
Level 3 (low-level) evidence
[10]
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 Jan 15:64(2):111-115. doi: 10.1093/cid/ciw778. Epub
[PubMed PMID: 28052967]
Level 1 (high-level) evidence
[11]
Jipa R,Olaru ID,Manea E,Merisor S,Hristea A, Rapid Clinical Score for the Diagnosis of Tuberculous Meningitis: A Retrospective Cohort Study. Annals of Indian Academy of Neurology. 2017 Oct-Dec;
[PubMed PMID: 29184338]
Level 2 (mid-level) evidence
[12]
Hristea A,Olaru ID,Baicus C,Moroti R,Arama V,Ion M, Clinical prediction rule for differentiating tuberculous from viral meningitis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2012 Jun;
[PubMed PMID: 22507645]
[13]
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Oct 1:63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10
[PubMed PMID: 27516382]
Level 1 (high-level) evidence
[14]
Nahid P,Mase SR,Migliori GB,Sotgiu G,Bothamley GH,Brozek JL,Cattamanchi A,Cegielski JP,Chen L,Daley CL,Dalton TL,Duarte R,Fregonese F,Horsburgh CR Jr,Ahmad Khan F,Kheir F,Lan Z,Lardizabal A,Lauzardo M,Mangan JM,Marks SM,McKenna L,Menzies D,Mitnick CD,Nilsen DM,Parvez F,Peloquin CA,Raftery A,Schaaf HS,Shah NS,Starke JR,Wilson JW,Wortham JM,Chorba T,Seaworth B, Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. American journal of respiratory and critical care medicine. 2019 Nov 15;
[PubMed PMID: 31729908]
Level 1 (high-level) evidence
[15]
Upton CM,Steele CI,Maartens G,Diacon AH,Wiesner L,Dooley KE, Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB). The Journal of antimicrobial chemotherapy. 2022 May 29
[PubMed PMID: 35257182]
[16]
Davis A,Meintjes G,Wilkinson RJ, Treatment of Tuberculous Meningitis and Its Complications in Adults. Current treatment options in neurology. 2018 Feb 28;
[PubMed PMID: 29492737]
[17]
Hsu PC,Yang CC,Ye JJ,Huang PY,Chiang PC,Lee MH, Prognostic factors of tuberculous meningitis in adults: a 6-year retrospective study at a tertiary hospital in northern Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2010 Apr;
[PubMed PMID: 20457427]
Level 2 (mid-level) evidence
[18]
Luo M,Wang W,Zeng Q,Luo Y,Yang H,Yang X, Tuberculous meningitis diagnosis and treatment in adults: A series of 189 suspected cases. Experimental and therapeutic medicine. 2018 Sep;
[PubMed PMID: 30210618]
Level 3 (low-level) evidence
[19]
Misra UK,Kalita J,Bhoi SK,Singh RK, A study of hyponatremia in tuberculous meningitis. Journal of the neurological sciences. 2016 Aug 15
[PubMed PMID: 27423581]
[21]
Garg RK,Malhotra HS,Kumar N,Uniyal R, Vision loss in tuberculous meningitis. Journal of the neurological sciences. 2017 Apr 15;
[PubMed PMID: 28320145]
[22]
Jiang Y,Xu X,Guo Z,Liu Y,Lin J,Suo L,Jiang Y,Liu B,Lu T, Myelitis: A Common Complication of Tuberculous Meningitis Predicting Poor Outcome. Frontiers in neurology. 2022;
[PubMed PMID: 35370906]
[23]
Silva DR,Rendon A,Alffenaar JW,Chakaya JM,Sotgiu G,Esposito S,Migliori GB, Global TB Network: working together to eliminate tuberculosis. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. 2018 Set-Oct;
[PubMed PMID: 30304206]